Pharmaceutical Reactivation of Attenuated Apoptotic Pathways Leads to Elimination of Osimertinib Drug-Tolerant Cells.

MCL1 inhibition via AZD5991 cotreatment at the DTP stage revealed a trend toward delayed regrowth, although this failed to reach statistical significance ( Fig. 4B ; Supplementary Fig.

also in 6,035 other papers